Europe Heart Failure Poc & Loc Devices Market Size & Outlook
Europe heart failure poc & loc devices market, 2018-2030 (US$M)
Related Markets
Europe heart failure poc & loc devices market highlights
- The Europe heart failure poc & loc devices market generated a revenue of USD 21.8 million in 2023.
- The market is expected to grow at a CAGR of 14.1% from 2024 to 2030.
- In terms of segment, proteomic testing was the largest revenue generating test type in 2023.
- Proteomic Testing is the most lucrative test type segment registering the fastest growth during the forecast period.
Europe data book summary
| Market revenue in 2023 | USD 21.8 million |
| Market revenue in 2030 | USD 54.7 million |
| Growth rate | 14.1% (CAGR from 2023 to 2030) |
| Largest segment | Proteomic testing |
| Fastest growing segment | Proteomic Testing |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Proteomic Testing |
| Key market players worldwide | Abbott Laboratories, Danaher Corp, Siemens Healthineers AG ADR, Roche, QuidelOrtho Corp, BioMerieux SA, Trinity Biotech PLC ADR, Abaxis |
Other key industry trends
- In terms of revenue, Europe region accounted for 22.8% of the global heart failure poc & loc devices market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 93.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Heart Failure POC & LOC Devices Market Scope
Heart Failure POC & LOC Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe heart failure poc & loc devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heart failure poc & loc devices market will help companies and investors design strategic landscapes.
Proteomic testing was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe heart failure poc & loc devices market based on proteomic testing covering the revenue growth of each sub-segment from 2018 to 2030.
Adoption of POC testing in hospital settings is continuously increasing across European countries. However, its usage is not high as in the U.S. A number of efforts by key stakeholders in the market to drive adoption of POC & LOC devices in the region are anticipated to boost revenue growth.
In June 2019, a conference titled “Point-of-Care, Biosensors & Mobile Diagnostics Europe 2019” was hosted by the Netherlands. This annual conference involved a discussion about the expanding POC tests and wearables, including microfluidics-based and LOC approaches, from innovative technologies to regulatory approval.
Furthermore, the European Society of Cardiology (ESC), involved in improving management of acute and chronic heart failure, is one of the key contributors in the Europe market. In 2016, ESC published guidelines regarding the diagnosis and treatment of chronic and acute heart failure in the region.
Reasons to subscribe to Europe heart failure poc & loc devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe heart failure poc & loc devices market databook
-
Our clientele includes a mix of heart failure poc & loc devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe heart failure poc & loc devices market , including forecasts for subscribers. This continent databook contains high-level insights into Europe heart failure poc & loc devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe heart failure poc & loc devices market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
